Back to News
Market Impact: 0.12
Zealand Pharma - Transactions related to share buy-back program (week 35, 2026)
Source: globenewswire.com
Capital Returns (Dividends / Buybacks)Company Fundamentals
Zealand Pharma announced transactions under its share buyback program for week 35 of 2026 (announcement dated August 31, 2026). The update provides buyback activity details but no major new financial or guidance information, implying limited near-term impact beyond routine capital-return operations.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.05
Ticker Sentiment
ZLDPF0.10
More News
- CoreWeave credit default swaps hit distress levels as investors sour on AI debt
- Penske Automotive agrees to be taken private by Penske, Mitsui
- Faraday Copper completes acquisition of BHP’s San Manuel project
- Supermicro promised a new CFO in December 2024. A $2.5 billion smuggling case and a co-founder’s arrest later, it has one
- Blackstone President Jon Gray Bets Big on AI Boom
- What's behind the sell-off in AI neocloud stocks like CoreWeave and Nebius
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- State of M&A and Private Markets, June 2026: A $4.9 Trillion Rebound, Underwritten on Money That Never Got Cheaper
- Run Cost-Controlled Financial Research in AllMind Agent Studio